title: Can we discontinue disease-modifying treatments in multiple sclerosis patients? Comments.
authors.affiliation: Service de neurologie, unité de recherche neurophysiologie clinique et électrodiagnostic 03/UR/08-09, hôpital Razi, rue des orangers, La Manouba, 2010 Tunis, Tunisie. Electronic address: rg@gnet.tn.
authors.forename: R
authors.initials: R
authors.lastname: Gouider
mesh_terms: D042241:Early Diagnosis; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000175:diagnosis / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000188:drug therapy*; D011256:Pregnancy Outcome; D028761:Withholding Treatment
chemical_list: D007166:Immunosuppressive Agents
keywords: Early identification; Multiple sclerosis; PML; Pregnancy; Treatment